University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Miguel Hernandez Pampaloni, M.D., Ph.D.


Dr. Miguel Hernandez Pampaloni is chief of Nuclear Medicine at UCSF Medical Center. Nuclear medicine is a specialized area of radiology that uses very small amounts of radioactive substances to examine organ function and structure. It also can be used to treat certain diseases.

Pampaloni earned a medical degree at Complutense University School of Medicine in Madrid, Spain. He completed training in nuclear medicine at the San Carlos Hospital, Complutense University, followed by a Ph.D. in 1998. He was a postdoctoral fellow in cardiovascular nuclear medicine at the David Geffen School of Medicine at UCLA. He was a clinical research fellow in PET cardiology at the Imperial College of Medicine, London, England. He completed a residency in nuclear medicine and worked at the University of Pennsylvania School of Medicine from 2004 to 2009, then joined UCSF, where he's an assistant professor in residence in radiology.


Imaging Center at China Basin
185 Berry St., Lobby 6, Suite 190
San Francisco, CA 94107
Scheduling: (415) 353-2573
Phone: (415) 353-4500
Fax: (415) 353-7140

Hours: Monday to Friday
7:30 a.m. – 5:30 p.m.

More about Miguel Hernandez Pampaloni

Additional Languages



Universidad Complutense School of Medicine 1991


Hospital Clinico San Carlos, Nuclear Medicine 1996
University of Pennsylvania Hospital, Nuclear Medicine 2008


UCLA Medical Center, Nuclear Radiology 2002
Imperial College, Hammersmith Hospital 2003

Selected Research and Publications

  1. Pampaloni MH, Nazer B, Botvinick E. Erratum to: Isolated right ventricular cardiac sarcoidosis demonstrated by (18)FDG positron emission tomography. J Nucl Cardiol. 2015 Feb; 22(1):221.
  2. Pampaloni MH, Nardo L. PET/MRI radiotracer beyond 8F-FDG. PET Clin. 2014 Jul; 9(3):345-9.
  3. Hernandez Pampaloni M, Nazar B, Botvinick E. Isolated right ventricular cardiac sarcoidosis demonstrated by 8FDG positron emission tomography. J Nucl Cardiol. 2014 Jun; 21(3):652-4.
  4. Ibrahim SF, Ahronowitz I, McCalmont TH, Hernandez Pampaloni M, Ryan JL, Yu SS. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study. Dermatol Surg. 2013 Sep; 39(9):1323-33.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.